Clinical Trial Update: Role of Adding Metformin to Neoadjuvant Chemotherapy in Patients With Breast Cancer (METNEO) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adding metformin to neoadjuvant chemotherapy in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Damanhour University | Conditions: Breast Cancer Female | Phase 2 | Status: COMPLETED